Paula J Foster Selected Research

ferric oxide (iron oxide)

1/2021	A method for the efficient iron-labeling of patient-derived xenograft cells and cellular imaging validation.
1/2020	Magnetic Particle Imaging of Macrophages Associated with Cancer: Filling the Voids Left by Iron-Based Magnetic Resonance Imaging.
1/2019	Cellular MRI Reveals Altered Brain Arrest of Genetically Engineered Metastatic Breast Cancer Cells.
6/2016	Investigating the Impact of a Primary Tumor on Metastasis and Dormancy Using MRI: New Insights into the Mechanism of Concomitant Tumor Resistance.
3/2016	Pre-Labeling of Immune Cells in Normal Bone Marrow and Spleen for Subsequent Cell Tracking by MRI.
6/2013	MRI detection of nonproliferative tumor cells in lymph node metastases using iron oxide particles in a mouse model of breast cancer.
8/2011	The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury.
7/2011	In vivo single scan detection of both iron-labeled cells and breast cancer metastases in the mouse brain using balanced steady-state free precession imaging at 1.5 T.
7/2010	Imaging iron-loaded mouse glioma tumors with bSSFP at 3 T.
11/2009	Three-dimensional imaging and quantification of both solitary cells and metastases in whole mouse liver by magnetic resonance imaging.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paula J Foster Research Topics

Disease

39	Neoplasms (Cancer) 12/2022 - 11/2006
18	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
17	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2008
11	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2011
6	Inflammation (Inflammations) 12/2019 - 04/2004
4	Spinal Cord Injuries (Spinal Cord Injury) 08/2011 - 01/2005
3	Melanoma (Melanoma, Malignant) 03/2011 - 03/2008
3	Glioma (Gliomas) 07/2010 - 02/2007
2	Carcinoma (Carcinomatosis) 01/2020 - 03/2011
2	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 07/2012
2	Multiple Sclerosis 03/2016 - 04/2004
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2016 - 07/2007
1	Ascites 05/2022
1	Ovarian Neoplasms (Ovarian Cancer) 05/2022
1	Ovarian Epithelial Carcinoma 05/2022
1	B-Cell Leukemia (Leukemia, B Cell) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Circulating Neoplastic Cells 01/2020
1	Osteoarthritis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Paralysis (Palsy) 03/2016
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Necrosis 10/2014
1	Lymphatic Metastasis 06/2013
1	Peripheral Arterial Disease 04/2013
1	Chronic Limb-Threatening Ischemia 04/2013
1	Ischemia 04/2013
1	Neoplasm Micrometastasis 07/2011
1	Liver Diseases (Liver Disease) 03/2011
1	Neuralgia (Stump Neuralgia) 11/2009
1	Pain (Aches) 11/2009
1	Cysts 05/2009
1	Communicable Diseases (Infectious Diseases) 04/2009

Drug/Important Bio-Agent (IBA)

22	IronIBA 11/2021 - 01/2005
15	ferric oxide (iron oxide)IBA 01/2021 - 04/2004
5	Contrast MediaIBA 01/2020 - 04/2004
3	FluorineIBA 12/2019 - 01/2017
3	VaccinesIBA 10/2016 - 04/2009
3	Gadolinium DTPA (Magnevist)FDA Link 04/2015 - 08/2005
2	RNA (Ribonucleic Acid)IBA 05/2022 - 11/2018
2	Firefly LuciferasesIBA 01/2022 - 10/2016
2	LuciferasesIBA 01/2021 - 01/2019
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 02/2019 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 06/2018
2	Peptides (Polypeptides)IBA 09/2015 - 12/2008
1	CytokinesIBA 05/2022
1	LigandsIBA 05/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	ferumoxides (Feridex)FDA Link 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Estrogen ReceptorsIBA 11/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2018
1	Messenger RNA (mRNA)IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	Nuclear Respiratory Factor 1IBA 11/2018
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2017
1	GlycopeptidesIBA 10/2016
1	CarbohydratesIBA 10/2016
1	Pharmaceutical PreparationsIBA 06/2016
1	SuperantigensIBA 01/2016
1	Therapeutic UsesIBA 09/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2014
1	Pyruvic Acid (Pyruvate)IBA 10/2014
1	Green Fluorescent ProteinsIBA 06/2013
1	Small Interfering RNA (siRNA)IBA 07/2011
1	bardoxoloneIBA 03/2011
1	TriterpenesIBA 03/2011
1	imidazoleIBA 03/2011
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 03/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2009
1	Monoclonal AntibodiesIBA 11/2009
1	IntegrinsIBA 11/2009
1	Aligeron (AS 2)IBA 05/2009
1	AntibodiesIBA 04/2009
1	Cytostatic AgentsIBA 04/2009
1	AminesIBA 12/2008
1	Hydroxyl RadicalIBA 12/2008
1	dendronIBA 12/2008
1	Guanidine (Guanidine Nitrate)FDA Link 12/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2008

Therapy/Procedure

14	Therapeutics 01/2022 - 11/2006
8	Immunotherapy 12/2022 - 11/2011
5	Radiotherapy 01/2022 - 06/2016
2	Cranial Irradiation 01/2018 - 10/2017
2	Transplantation 04/2013 - 08/2011
1	Traction 01/2022
1	Subcutaneous Injections 01/2022
1	Microspheres (Microsphere) 01/2022
1	Precision Medicine 01/2020
1	Intravenous Injections 01/2020
1	Aftercare (After-Treatment) 06/2018
1	Injections 10/2016
1	Cell Transplantation 04/2013
1	Oral Administration 03/2011
1	Treatment Delay 11/2009